Skip to main content

Showing 1–2 of 2 results for author: Stenzinger, A

.
  1. arXiv:2309.03652  [pdf, other

    eess.IV cs.AI cs.CV

    Anatomy-informed Data Augmentation for Enhanced Prostate Cancer Detection

    Authors: Balint Kovacs, Nils Netzer, Michael Baumgartner, Carolin Eith, Dimitrios Bounias, Clara Meinzer, Paul F. Jaeger, Kevin S. Zhang, Ralf Floca, Adrian Schrader, Fabian Isensee, Regula Gnirs, Magdalena Goertz, Viktoria Schuetz, Albrecht Stenzinger, Markus Hohenfellner, Heinz-Peter Schlemmer, Ivo Wolf, David Bonekamp, Klaus H. Maier-Hein

    Abstract: Data augmentation (DA) is a key factor in medical image analysis, such as in prostate cancer (PCa) detection on magnetic resonance images. State-of-the-art computer-aided diagnosis systems still rely on simplistic spatial transformations to preserve the pathological label post transformation. However, such augmentations do not substantially increase the organ as well as tumor shape variability in… ▽ More

    Submitted 7 September, 2023; originally announced September 2023.

    Comments: Accepted at MICCAI 2023

  2. arXiv:1805.11178  [pdf, other

    cs.CV

    Towards computational fluorescence microscopy: Machine learning-based integrated prediction of morphological and molecular tumor profiles

    Authors: Alexander Binder, Michael Bockmayr, Miriam Hägele, Stephan Wienert, Daniel Heim, Katharina Hellweg, Albrecht Stenzinger, Laura Parlow, Jan Budczies, Benjamin Goeppert, Denise Treue, Manato Kotani, Masaru Ishii, Manfred Dietel, Andreas Hocke, Carsten Denkert, Klaus-Robert Müller, Frederick Klauschen

    Abstract: Recent advances in cancer research largely rely on new developments in microscopic or molecular profiling techniques offering high level of detail with respect to either spatial or molecular features, but usually not both. Here, we present a novel machine learning-based computational approach that allows for the identification of morphological tissue features and the prediction of molecular proper… ▽ More

    Submitted 28 May, 2018; originally announced May 2018.